Methionine: Biological Roles and Key Points for Research Application

Methionine (Met) is a sulfur-containing essential amino acid and a key node in protein synthesis, one-carbon metabolism and methylation networks, and redox homeostasis maintained via the transsulfuration pathway. Its biological significance extends beyond being a protein building block: Met supplies the universal methyl donor S-adenosylmethionine (SAM) and, through the homocysteine (Hcy) branch point, contributes to cysteine (Cys) and glutathione (GSH) synthesis. Through these routes, methionine influences epigenetic regulation, cell proliferation and differentiation, immunometabolism, and stress adaptation. Because methionine availability, metabolic flux, and downstream readouts are tightly coupled, both basic and applied studies require strict control of nutritional background and multi-layer endpoint integration.

Keywords: methionine; SAM; SAH; one-carbon metabolism; methylation; homocysteine; transsulfuration pathway; glutathione; redox homeostasis; nutrient sensing

I. Core Positioning: Essential Amino Acid and Sulfur-Metabolism Hub

1.1 Essentiality and dependence on external supply

(1) Essential amino acid property:

Humans and most animals cannot synthesize methionine de novo and must obtain it from diet or culture media to maintain nitrogen balance and protein synthesis.

(2) Sulfur entry point:

The sulfur atom in Met makes it a major entry point for sulfur metabolism, setting the potential and upper flux bounds for multiple sulfur-containing metabolites.

1.2 Roles in protein synthesis

(1) Translation initiation:

Eukaryotic translation initiation requires Met charged onto initiator tRNA to form the initiation complex. Subsequent N-terminal processing may remove initiator Met from some proteins but does not change its essential role at initiation.

(2) Structural contribution:

Met’s hydrophobicity and oxidizable thioether support common roles in hydrophobic cores, membrane-protein stability, and certain ligand-binding microenvironments.

II. One-Carbon Metabolism and Methyl-Donor Function

2.1 SAM generation and methylation networks

(1) SAM generation:

Met is converted to SAM by methionine adenosyltransferase (MAT).

(2) Universal methyl donor:

SAM donates methyl groups for methylation of DNA, RNA, histones, and many small molecules (e.g., phospholipids and metabolic intermediates), forming the central supply for cellular methylation capacity.

(3) Systems-level effects:

Altered methylation can reshape chromatin structure, transcriptional programs, and RNA modification landscapes, producing measurable phenotypic consequences in fate decisions, tumor metabolic reprogramming, and immune-cell differentiation.

2.2 SAH and constraints on methylation potential

(1) Product inhibition by SAH:

After methyl donation, SAM becomes S-adenosylhomocysteine (SAH), which product-inhibits multiple methyltransferases.

(2) SAM/SAH ratio:

Commonly used as an integrated indicator of methylation potential, reflecting combined effects of Met supply, one-carbon cycle efficiency, and SAH clearance capacity.

III. Homocysteine Cycling and the Transsulfuration Pathway

3.1 Methionine cycle and remethylation replenishment

(1) Hcy generation:

SAH hydrolysis produces Hcy, a branch point between the methionine cycle and transsulfuration.

(2) Remethylation:

Under folate-cycle and vitamin B12-dependent reactions, Hcy can be remethylated to Met, maintaining Met pools and SAM supply homeostasis.

3.2 Transsulfuration and antioxidant outputs

(1) Cys generation:

Hcy can enter transsulfuration to generate Cys, supplying substrates for sulfur-containing metabolite synthesis.

(2) GSH synthesis:

Cys is a rate-limiting substrate for GSH synthesis, so transsulfuration flux directly influences GSH levels, the GSH/GSSG ratio, and antioxidant thresholds.

(3) Stress adaptation:

The GSH system supports peroxide clearance, detoxification of electrophiles, and thiol repair, and is important for survival and function under inflammation, hypoxia, and drug-induced stress.

IV. Nutrient Sensing and Cellular Signaling

4.1 Growth and anabolic regulation

(1) Essential amino acid supply signaling:

As part of the essential amino acid landscape, Met availability can shift growth-related signaling and alter protein synthesis capacity and proliferation rates.

(2) mTORC1 context:

Amino acids, energy status, and growth factors jointly determine mTORC1 activity. Met effects are typically coupled to multi-variable context and require control of amino acid composition and energy substrate background.

4.2 Coupling between redox state and inflammatory signaling

(1) ROS modulation:

By supporting transsulfuration-driven GSH supply, Met can modulate ROS load and redox signaling readouts, influencing inflammation-related pathways such as NF-κB.

(2) Methylation-mediated immune regulation:

The Met–SAM axis can reprogram immune differentiation and effector gene expression via epigenetic and transcriptional regulation.

V. Representative Research Directions and Experimental Paradigms

5.1 Tumor metabolism and methionine dependence

(1) Proliferation sensitivity:

Subsets of tumor cells exhibit strong dependence on external Met, supporting studies of amino acid dependence, metabolic vulnerabilities, and selective pressures.

(2) Mechanistic integration:

Met restriction can simultaneously shift SAM/SAH, nucleotide synthesis flux, and replication-stress readouts. Integrating metabolomics with cell-cycle endpoints strengthens causal interpretation.

5.2 Epigenetics and development/differentiation

(1) Methylation landscape remodeling:

Manipulating Met or SAM supply enables evaluation of DNA/histone/RNA methylation changes and lineage outcomes.

(2) Time structure:

Methylation and transcriptional remodeling often show lag relative to acute metabolic perturbation; multi-timepoint sampling helps separate acute metabolic effects from chronic epigenetic reprogramming.

5.3 Oxidative stress and regulated cell-death modes

(1) GSH-axis readouts:

Met restriction or supplementation shifts Cys supply and GSH levels, affecting lipid peroxidation and antioxidant-enzyme homeostasis.

(2) Ferroptosis context:

In models driven by GSH depletion and lipid peroxidation, Met–transsulfuration–GSH flux can be a key regulator. Use GSH/GSSG, lipid peroxidation endpoints, and rescue experiments to build a closed evidence loop.

5.4 Immunometabolism and inflammatory phenotypes

(1) Functional readouts:

Met supply influences immune transcriptional programs via SAM. Combine cytokine panels, metabolic flux, and methylation markers.

(2) Normalization principle:

Normalize functional readouts by cell number, protein, or DNA to reduce confounding from Met-driven proliferation differences.

VI. Practical Notes and Quality Control in Research

6.1 Controlling nutritional background and input sources

(1) Media differences:

Different media formulations vary in Met, Cys, folate, choline, B vitamins, and trace elements, shifting Met–SAM–SAH states. Record full formulations and use same-lot ingredients where possible.

(2) Serum inputs:

Serum, albumin, and supplements can introduce Met, Cys, or methyl donors, producing mismatches between nominal and actual restriction. Use dialyzed serum or directly measure free amino acids.

(3) Cell-density effects:

High-density culture can rapidly deplete Met and accumulate byproducts, generating nonlinear effects. Control seeding density, define feeding strategies, and record endpoint Met concentrations.

6.2 Separating methyl-donor effects from sulfur-donor effects

(1) Decomposition strategies

① Supplement SAM or perturb the MAT axis to assess methyl-donor chain contributions.

② Supplement Cys or GSH precursors to assess transsulfuration–antioxidant contributions.

③ Perturb folate/B12 modules to validate effects of remethylation replenishment.

(2) Linked metrics:

Measure SAM, SAH, Hcy, and GSH/GSSG together to avoid pathway-state inference from single metabolites.

6.3 Managing Hcy accumulation and toxicity confounding

(1) Risk source:

Higher Met load or insufficient remethylation can elevate Hcy, inducing oxidative stress and protein modifications that confound specificity.

(2) Controls:

Include Hcy monitoring and, when needed, adjust folate/B12 conditions or use iso-osmotic control supplementation strategies to validate specificity.

6.4 Time scales and endpoint hierarchy

(1) Metabolite shifts and epigenetic changes occur on different time scales; a single time point should not be used to support both flux inference and transcriptional remodeling claims.

(2) Use a two-window design:

Early metabolic readouts and later epigenetic/functional readouts, with multi-layer consistency checks.

6.5 Data normalization and batch-effect management

(1) Normalization:

Normalize secreted factors, ROS, and metabolites to cell number, protein, or DNA to avoid systematic bias from proliferation differences.

(2) Batch control:

For omics studies, include internal QC and bridging samples and standardize sample handling workflows.

VII. Common Readouts and Method Combinations

7.1 Metabolites and flux

(1) Met, SAM, SAH, Hcy, Cys, GSH/GSSG:

Core panel for locating methionine-cycle and transsulfuration states.

(2) Isotope tracing:

Labeled Met tracing can resolve relative contributions of methyl flux versus sulfur flux into downstream outputs.

7.2 Epigenetic and expression readouts

(1) DNA methylation:

Global levels or locus-specific methylation.

(2) Histone methylation marks:

E.g., H3K4me3 and H3K27me3, linking SAM supply to chromatin state.

(3) Transcriptome integration:

Identify perturbed metabolic and stress modules and validate consistency with metabolite shifts.

VIII. Aladdin-Related Products

8.1 Methionine Supply, Isotope Tracing, and Met–SAM Axis Tool Products

Catalog No.	Product Name	CAS No.	Grade and Purity
M101130	L-Methionine	63-68-3	Moligand™, ≥99%
L425234	L-Methionine	63-68-3	Moligand™, 10mM in Water
M101131	L-Methionine	63-68-3	Animal Free, USP, JP, Moligand™, Ph.Eur, for cell culture, ≥99%
D424961	DL-Methionine	59-51-8	10mM in Water
M104886	DL-Methionine	59-51-8	≥99%
D1045686	d-Methionine sulfoxide	21056-56-4	≥98%
L473919	L-Methionine-(methyl-¹³C)	49705-26-2	≥99 atom% ¹³C, ≥98%
L473970	L-Methionine-1-¹³C	81202-04-2	≥99 atom% ¹³C, ≥98%
L471886	L-Methionine-¹³C₅,¹⁵N	202468-47-1	≥99 atom% ¹³C5, ≥99 atom% ¹⁵N, ≥98%
L133003	L-Methionine-(methyl-d3)	13010-53-2	≥98 atom% D
R341484	S-(5'-Adenosyl)-L-methionine p-toluenesulfonate salt	52248-03-0	≥97%
S139354	S-(5′-Adenosyl)-L-methionine chloride dihydrochloride	86867-01-8	≥75%
S693949	S-adenosylmethionine	485-80-3	32mM±2mM
B287662	BRD 4770	1374601-40-7	Moligand™, ≥98%(HPLC)
S1433377	S-Adenosylmethionine synthetase	9012-52-6
A113377	N-Acetyl-DL-methionine	1115-47-5	≥99%
N420624	N-Acetyl-DL-methionine	1115-47-5	10mM in DMSO

8.2 Key Reagents Commonly Used for Methionine One-Carbon Metabolism, Remethylation, and Transsulfuration/Antioxidant-Axis Research

Category	Reagent Name	CAS No.	Workflow Step	Role in the System	Use Notes
Remethylation module	Folic acid	59-30-3	Remethylation support	Supports folate cycle, affecting Hcy→Met replenishment efficiency and methyl-donor homeostasis	Strongly coupled with B12; use paired “±folate/±B12” designs
Remethylation module	Cyanocobalamin (vitamin B12)	68-19-9	Remethylation support	Supports methionine-synthesis-related reactions, influencing Hcy levels and Met recovery	Media/serum may already contain B12; record total inputs
Alternative methyl donor	Betaine	107-43-7	BHMT-pathway validation	Alternative methyl donor to validate contributions of different remethylation routes	Pathway depends on cell type; monitor Hcy and Met recovery
Methyl-donor precursor	Choline chloride	67-48-1	Methyl-donor network modeling	Choline→betaine axis shapes methyl-donor supply and methylation potential	Strongly background-dependent; full formulation and lot consistency needed
Branch-point control	Homocysteine	6027-13-0	Hcy confounding/toxicity control	Builds Hcy-elevation context to separate “methyl-donor deficiency” from “Hcy toxicity”	Concentration window is sensitive; pair with oxidative-stress and cytotoxicity readouts
Transsulfuration/sulfur-donor axis	L-Cysteine	52-90-4	Transsulfuration-output decomposition	Directly supplements downstream sulfur substrate to test “sulfur-donor/antioxidant output” contribution	Oxidation-prone; prepare fresh and protect from light; strongly interacts with media background
Transsulfuration/sulfur-donor axis	L-Cystine	56-89-3	Media background control	Common extracellular input form affecting Cys availability and GSH synthesis	Transporter and redox-environment dependent; use time series and endpoint measurement
Antioxidant output	Reduced glutathione (GSH)	70-18-8	Endpoint/rescue	Direct antioxidant supplementation to test “GSH deficiency → phenotype” causality	Uptake can be limited; use precursor strategies when needed; measure GSH/GSSG
Antioxidant output	Oxidized glutathione (GSSG)	27025-41-8	Redox-state calibration	Paired with GSH for GSH/GSSG ratio and oxidative-pressure readouts	Rapid, cold handling needed; avoid ex vivo oxidation artifacts
GSH precursor/rescue	N-Acetylcysteine (NAC)	616-91-1	Antioxidant rescue/mechanism decomposition	Provides usable sulfur and elevates GSH synthesis capacity to validate transsulfuration→GSH chain	Reducing agent interferes with ROS probes/colorimetry; blanks are mandatory
GSH synthesis blockade	L-Buthionine sulfoximine (BSO)	83730-53-4	Mechanism validation	Inhibits γ-GCS to deplete GSH and test GSH-dependent phenotypes (including ferroptosis contexts)	Use dose–time matrices and measure GSH/GSSG in parallel
Oxidative-stress model	tert-Butyl hydroperoxide (tBHP)	75-91-2	Oxidative-stress induction	Induces ROS/lipid peroxidation to test Met–transsulfuration–GSH effects on antioxidant thresholds	Narrow window; require cytotoxicity curves and time series
Oxidative-stress model	Hydrogen peroxide (H2O2)	7722-84-1	Oxidative-stress induction	Builds controlled oxidative pressure linking GSH consumption to stress responses	Prepare fresh; metals amplify reactions; keep systems consistent
ROS detection	DCFH-DA	4091-99-0	Cellular ROS readout	General ROS probe for comparing ROS loads under Met restriction/supplementation	Sensitive to reducers/autofluorescence; use comprehensive control matrices
Thiol quantitation	DTNB (Ellman’s reagent)	69-78-3	Thiol/reduced-state profiling	Quantifies free thiols to support redox-state and protein-thiol occupancy assessments	Strongly interfered by reducers; remove DTT/NAC backgrounds
Thiol blocking	N-Ethylmaleimide (NEM)	128-53-0	Sample pre-treatment	Rapid thiol blocking to reduce post-sampling oxidation/exchange artifacts	Timing determines credibility; “immediate quench at sampling” is recommended
Protein thiol alkylation	Iodoacetamide (IAA)	144-48-9	Proteomics/thiol-state fixation	Fixes thiol states for downstream quantitation and omics analysis	Light sensitive; control pH and time to avoid side reactions

Methionine links three primary axes, protein synthesis supply, SAM-driven methylation, and transsulfuration-driven antioxidant output, thereby coupling growth, epigenetics, redox balance, and immune functions across phenotype layers. In research, conclusion robustness depends on controlling nutritional background and inputs, separating methyl-donor versus sulfur-donor contributions, managing Hcy confounding, and using time-scale-stratified designs. An integrated readout centered on Met–SAM–SAH–Hcy and the GSH system, complemented by tracing and multi-omics, is recommended to build causal evidence chains that are reproducible, comparable, and mechanistically interpretable.